Complexes of lysine, histidine, and arginine with sulfonated azo dyes: Model systems for understanding the biomolecular recognition of glycosaminoglycans by proteins

Journal of the American Chemical Society

Volumn 118, Issue 9, 1996, Pages 2131-2142

  Ojala, William H ^b   Sudbeck, Elise A ^c   Lu, Linh Khanh ^b   Richardson, Timothy I ^b   Lovrien, Rex E ^b   Gleason, William B ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZO DYE; GLYCOSAMINOGLYCAN; LYSINE;

ARTICLE; COMPLEX FORMATION; DRUG PROTEIN BINDING; MODEL; X RAY CRYSTALLOGRAPHY;

EID: 0029868693     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja951121f     Document Type: Article

References (77)

1. (a) Mohan, P. Pharm. Res. 1992, 9, 703-714.
2. (b) Baba, M.; Schols, D.; Mohan, P.; De Clercq, E.; Shigeta, S. Antiviral Chem. Chemother. 1993, 4, 229-234.
3. (c) Weaver, J. L.; Pine, P. S.; Anand, R.; Bell, S.; Aszalos, A. Antiviral Chem. Chemother. 1992, 3, 147-151.
4. (d) Mohan, P.; Singh, R.; Baba, M. J. Med. Chem. 1991, 34, 212-217.
5. (e) García-Villalón, D.; Gil-Fernández, C. Antiviral Chem. Chemother. 1992, 3, 9-14.
6. (a) Brinkworth, R. I.; Fairlie, D. P. Biochem. Biophys. Res. Commun. 1992, 188, 624-630.
7. (b) Balzarini, J.; Mitsuya, H.; De Clercq, E.; Broder, S. Int. J. Cancer 1986, 37, 451-457.
8. (a) Turnell, W. G.; Finch, J. T. J. Mol. Biol. 1992, 227, 1205-1223.
9. (b) Klunk, W. E.; Pettegrew, J. W.; Abraham, D. J. J. Histochem. Cytochem. 1989, 37, 1273-1281.
10. Zhang, S.; Holmes, T.; Lockshin, C.; Rich, A. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 3334-3338.
11. (a) Caughey, B.; Ernst. D.; Race, R. E. J. Virol. 1993, 67, 6270-6272.
12. (b) Caughey, B.; Race, R. E. J. Neurochem. 1992, 59, 768-771.
13. Mohan, P.; Hopfinger, A. J.; Baba, M. Antiviral Chem. Chemother. 1991, 2, 215-222.
14. Sachsenmaier, C.; Radler-Pohl, A.; Zinck, R.; Nordheim, A.; Herrlich, P.; Rahmsdorf, H. J. Cell 1994, 78, 963-972.
15. Gagliardi, A.; Hadd, H.; Collins, D. C. Cancer Res. 1992, 52, 5073-5075.
16. Jozefowicz, M.; Jozefonvicz, J. Pure Appl. Chem. 1984, 56, 1335-1344.
17. (a) Hardingham, T. E.; Fosang, A. J. FASEB J. 1992, 6, 861-870.
18. (b) Sugiura, N.; Sakurai, K.; Hori, Y.; Karasawa, K.; Suzuki, S.; Kimata, K. J. Biol. Chem. 1993, 268, 15779-15787.
19. (a) Whirfield, D. M.; Tang, T.-H. J. Am. Chem. Soc. 1993, 115, 9648-9654.
20. (b) Lamba, D.; Glover, S.; Mackie, W.; Rashid, A.; Sheldrick, B.; Pérez, S. Glycobiology 1994, 4, 151-163.
21. (c) Zsiška, M.; Meyer, B. Carbohydr. Res. 1993, 243, 225-258.
22. (d) Polvorinos, A. J.; Contreras, R. R.; Martin-Ramos, D.; Romero, J.; Hidalgo, M. A. Carbohydr. Res. 1994, 257, 1-10.
23. (e) Lamba, D.; Mackie, W.; Rashid, A.; Sheldrick, B.; Yates, E. A. Carbohydr. Res. 1993, 241, 89-98.
24. (f) Kanters, J. A.; van Dijk, B.; Kroon, J. Carbohydr. Res. 1991, 212, 1-11.
25. (g) Lamba, D.; Mackie, W.; Sheldrick, B.; Belton, P.; Tanner, S. Carbohydr. Res. 1988, 180, 183-193.
26. (a) Ito, M.; Baba, M.; Shigeta, S.; Wada, S.; Takagi, M.; Kimura, T.; Okuyama, T. Antiviral Chem. Chemother. 1991, 2, 41-44.
27. (b) McClure, M. O.; Whitby, D.; Patience, C.; Gooderham, N. J.; Bradshaw. A.; Cheingsong-Popov, R.; Weber, J. N.; Davies, D. S.; Cook, G. M. W.; Keynes, R. J.; Weiss, R. A. Antiviral Chem. Chemother. 1991, 2, 149-156.
28. (c) Witvrouw, M.; Schols, D.; Andrei, G.; Snoeck, R.; Hosoya, M.; Pauwels, R.; Balzarini, J.; De Clercq, E. Antiviral Chem. Chemother. 1991, 2. 171-179.
29. (d) Schols, D.; De Clercq, E.; Witvrouw, M.; Nakashima, H.; Snoeck, R.; Pauwels, R.; Van Schepdael, A.; Claes, P. Antiviral Chem. Chemother. 1991, 2, 45-53.
30. (e) Anand, R.; Nayyar, S.; Pitha, J.; Merril, C. R. Antiviral Chem Chemother. 1990, 1, 41-46.
31. (f) Kozlowski, M. R.; Watson, A. Antiviral Chem. Chemother. 1990, 1, 175-182.
32. (g) Otake, T.; Schols, D.; Witvrouw, M.; Naesens, L.; Nakashima, H.; Moriya, T.; Kurita. H.; Matsumoto, K.; Ueba, N.; De Clercq, E. Antiviral Chem. Chemother. 1994, 5, 155-161.
33. Schols, D.; De Clercq, E.; Balzarini, J.; Baba, M.; Witvrouw, M.; Hosoya, M.; Andrei, G.; Snoeck, R.; Neyts, J.; Pauwels, R.; Nagy, M.; Györgyi-Edelényi, J.; Machovich, R.; Horváth, I.; Löw, M.; Görög, S. Antiviral Chem. Chemother. 1990, 1, 233-240.
34. Kisilevsky, R.; Lemieux, L. J.; Fraser, P. E.; Kons, X.; Hultin, P. G.; Szarek, W. A. Nature Med. 1995, 1, 143-148.
35. Ojala, W. H.; Ojala, C. R.; Gleason, W. B. Antiviral Chem. Chemother. 1995, 6, 25-33.
36. Kanyo, Z. F.; Christianson, D. W. J. Biol. Chem. 1991, 266, 4264-4268.
37. Chakrabarti, P. Int. J. Peptide Protein Res. 1994, 43, 284-291.
38. Nawata, Y.; Ochi, K.; Shiba, M.; Monta, K., Iitaka, Y. Acta Crystallogr. 1981, B37, 246-249.
39. Zhu, X.; Hsu, B. T.; Rees, D. C. Structure 1993, 1, 27-34.
40. (a) Ojala, W. H.; Gleason, W. B.; Richardson, T. I.; Lovrien, R. E. Acta Crystallogr. 1994, C50. 1615-1620.
41. (b) Ojala, W. H.; Lu, L. K.; Albers, K. E.; Gleason, W. B.; Richardson, T. I.; Lovrien, R. E.; Sudbeck. E. A. Acta Crystallogr. 1994, B50, 684-694.
42. Ojala, W. H.; Albers, K. E.; Gleason, W. B.; Choo, C. G. Carbohydr. Res. 1995, 275, 49-65.
43. (a) Sudbeck, E. A.; Etter, M. C.; Gleason, W. B. Chem. Mater. 1994, 6, 1192-1199.
44. (b) Garber, L. T.; Haltiwanger, R. C.; Eggleston, D. S. Lett. Peptide Sci. 1994, 1, 127-133.
45. (c) Krause, J. A.; Baures, P. W.; Eggleston, D. S. Acta Crystallogr. 1993, B49, 123-130.
46. (d) Conroy, M. J.; Lovrien, R. E. J. Cryst. Growth 1992, 122, 213-222.
47. (e) Kimoto, H.; Saigo, K.; Ohashi, Y.; Hasegawa, M. Bull. Chem. Soc. Jpn. 1989, 62, 2189-2195.
48. (f) Yamada, S.; Yamamoto, M.; Chibata, I. J. Org. Chem. 1973, 38, 4408-4412.
49. (g) van der Veen, J. M.; Low, B. W. Acta Crystallogr. 1972, B28, 3548-3559.
50. (h) Stein, W. H.; Moore, S.; Bergmann,. M. J. Biol. Chem. 1944, 154, 191-201.
51. (i) Bergmann, M.; Stein, W. H. J. Biol. Chem. 1939, 129, 609-618.
52. (j) Crosby, B. L.; Kirk, P. L. Mikrochemie 1935, 18, 137-143.
53. (k) Fischer, E.; Beraell, P. Ber. Dtsch. Chem. Ges. 1902, 35, 3779-3787.
54. (a) Etter, M. C. Acc. Chem. Res. 1990, 23, 120-126.
55. (b) Etter, M. C.; MacDonald, J. C.; Bernstein, J. Acta Crystallogr. 1990, B46, 256-262.
56. (c) Bernstein, J.; Etter, M. C.; MacDonald, J. C. J. Chem. Soc., Perkin Trans. 2 1990, 695-698.
57. (d) Etter, M. C. J. Phys. Chem. 1991, 95, 4601-4610.
58. (e) Bernstein, J.; Davis, R. E.; Shimoni, L.; Chans, N.-L. Angew. Chem., Int. Ed. Engl. 1995, 34, 1555-1573.
59. Enraf-Nonius. CAD-4 Software, Version 5.0: Enraf-Nonius: Delft, The Netherlands, 1989.
60. Molecular Structure Corp. MSC/AFC Diffractometer Control Software; MSC, 3200 Research Forest Dr., The Woodlands, TX 77381, 1988.
61. Sheldrick, G. M. SHELXS86. Program for the Solution of Crystal Structures; University of Göttingen: Göttingen, Germany, 1985.
62. Molecular Structure Corp. TEXSAN-TEXRAY Structure Analysis Package: MSC, 3200 Research Forest Dr., The Woodlands, TX 77381, 1985.
63. Johnson, C. K. ORTEPII. Report ORNL-5138; Oak Ridge National Laboratory: Oak Ridge, TN, 1976.
64. Motherwell, W. D. S.; Clegg, W. PLUTO. Program for Plotting Molecular and Crystal Structures; University of Cambridge: Cambridge, England, 1976.
65. Olivieri, A. C.; Wilson, R. B.; Paul, I. C.; Curtin, D. Y. J. Am. Chem. Soc. 1989, 111, 5525-5532.
66. Leiserowitz, L. Acta Crystallogr. 1976, B32, 775-802.
67. (a) Russell, V. A.; Etter, M. C.; Ward, M. D. J. Am. Chem. Soc. 1994, 116, 1941-1952.
68. (b) Russell, V. A.; Etter, M. C.; Ward, M. D. Chem. Mater. 1994, 6, 1206-1217.
69. Wells, A. F. Structural Inorganic Chemistry: Clarendon Press: Oxford, 1962; pp 294-315.
70. Hamilton, W. C.; Ibers, J. A. Hydrogen Bonding in Solids; W. A. Benjamin: New York, 1968; pp 19-21.
71. Kuleshova, L. N.; Zorky, P. M. Acta Crystallogr. 1980, B36, 2113-2115.
72. (a) Bernstein, J. Acta Crystallogr. 1991, B47, 1004-1010.
73. (b) Shimoni, L.; Carrell, H. L.; Glusker, J. P.; Coombs, M. M. J. Am. Chem. Soc. 1994, 116, 8162-8168.
74. (c) Aakeröy, C. B.; Nieuwenhuyzen, M. J. Am. Chem. Soc. 1994, 116, 10983-10991.
75. (d) Several other examples can be found in Chem. Mater. 1994, 6.
76. Shimoni, L.; Glusker, J. P. Protein Sci. 1995, 4, 65-74.
77. Our criterion for an "eclipsed" sulfonate conformation is that the S-O bond most nearly coplanar with the naphthalene ring be located within a torsional angle of 15° with respect to the ring.